Lapatinib Terminated Phase 2 Trials for Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00239200Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus